Search for information about a product,
therapeutic area or event

Media, investors, advocacy organizations and others, please contact us here.

Decorative image of Prague

International Symposium on IgA Nephropathy

Upcoming
September 17-20, 2025

Topics: Nephrology

Location: Prague, Czech Republic
Type: In-person
Share:
Home » Meetings & Events » IIgANN 2025



The International Symposium on IgA Nephropathy is the meeting of the International IgA Nephropathy Network (IIgANN). The conference showcases research on IgAN from across the globe.

Travere at IIgANN 2025

Travere Therapeutics is excited to participate in the 18th International Symposium on IgA Nephropathy and engage with researchers and renal healthcare professionals from around the world.


Wednesday to Saturday, September 17-20

Nephrology

Sparsentan (SPAR) Added to Stable Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2is) in Adults With IgA Nephropathy (IgAN) in the Phase 2 SPARTACUS Trial

Speakers: Sydney CW Tang, Isabelle Ayoub, Laura Ann Kooienga, Priscila Preciado, David S Lee, Radko Komers, Bruce Hendry, Alex Mercer, Stephanie Moody, Brad H Rovin

Type: Poster and Visual Abstract – Coming Soon

Time:
Wednesday, 4:00 p.m. to Saturday, 6:00 p.m. (CET)

Travere MSLs

Contact your Travere MSL

Our Medical Science Liaisons (MSLs) are available to answer questions and provide support on Travere products.

Schedule a meeting
Nephrology

Urinary biomarker analysis reveals rapid intrarenal anti-inflammatory and anti-fibrotic effects of sparsentan in IgA nephropathy in the SPARTAN study

Speakers: Chee Kay Cheung, William A Barratt, Sulalita Chaki, Silpa Chinnakotla, Neeraj Dhaun, Siân Griffin, Bruce Hendry, Amal A A Jama, Wenjun Ju, Ishika Khan, Radko Komers, Alex Mercer, Viji Nair, Nadia Nawaz, Matthew Sayer, Smeeta Sinha, Lisa Willcocks, Matthias Kretzler, Jonathan Barratt

Type: Poster – Coming Soon

Time:
Friday: 4:00 p.m. – 5:00 p.m. (CET)

Nephrology

Sparsentan as First-Line Treatment of Incident Patients With IgA Nephropathy: An Interim Analysis of the SPARTAN Trial Evaluating Efficacy and Cardiovascular Risk Variables

Speakers: Chee Kay Cheung, Neeraj Dhaun, Matthew Graham-Brown, Siân Griffin, Bruce Hendry, Alexandra Howson, Radko Komers, Alex Mercer, Kelly Parke, Stephanie Moody, Matthew Sayer, Smeeta Sinha, Lisa Willcocks, Jonathan Barratt

Type: Poster and Summary – Coming Soon

Time:
Wednesday, 4:00 p.m. to Saturday, 6:00 p.m. (CET)

Nephrology

Sparsentan decreases mesangial IgA deposition in gddY mice; a possible role for mesangial-cell-surface autoantigen expression

Speakers: Kazuaki Mori, Yoshihito Nihei, Celia Jenkinson, Bruce Hendry, Hitoshi Suzuki, Yusuke Suzuki

Type: Poster – Coming Soon

Time:
Friday, 4:00 p.m. – 5:00 p.m. (CET)

Decorative image of Prague

Join Travere at the 18th International Symposium on IgA Nephropathy (IIgANN) 2025!

Travere Medical Affairs team members will be at the 18th International Symposium on IgA Nephropathy (IIgANN) 2025.
We look forward to connecting with you in Prague this September!

Learn more & register

MA-DS-25-0075 | August 2025